Testing a new heart pump for high-risk heart patients
Part of Heart & circulation clinical trials.
This trial tests a new device called the VentriCure that helps the heart pump blood. It is for people with severe coronary artery disease and a weak heart who cannot have bypass surgery or choose not to.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have coronary artery disease and a weakened heart (ejection fraction 35% or less, or 40% or less with severe heart failure).
- You need a procedure to open blocked arteries (PCI), but bypass surgery is too risky or you decided against it.
- You do not have serious kidney disease, severe bleeding risk, or an active infection.
- You are willing to come for follow-up visits and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device called Ventiflow LP that supports the heart during high-risk stent placement (PCI) in people whose hearts are weak or have complex blockages. It may be an option if surgery is too risky or you prefer not to have it.
This trial tests a new device called Phimume® that helps your heart pump blood. It is for people with severe heart failure who cannot have standard open-heart surgery because it is too risky. The device is placed without cutting open your chest.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
This trial tests the iVAC 2L device, a temporary heart pump placed in the main artery, to help patients who need a high-risk angioplasty (PCI) because of a very narrowed or blocked coronary artery. The goal is to prevent the heart from failing during the procedure.
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.